Zhenru Wu

2.5k total citations · 1 hit paper
94 papers, 1.7k citations indexed

About

Zhenru Wu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Zhenru Wu has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 26 papers in Surgery and 26 papers in Cancer Research. Recurrent topics in Zhenru Wu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), RNA modifications and cancer (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Zhenru Wu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), RNA modifications and cancer (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Zhenru Wu collaborates with scholars based in China, United States and Nepal. Zhenru Wu's co-authors include Yujun Shi, Yongjie Zhou, Hong Bu, Yong Zeng, Mingyang Shao, Xiaoyue Cao, Qing Xu, Yuwei Chen, Menglin Chen and Xiang Zhuang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cancer Research.

In The Last Decade

Zhenru Wu

91 papers receiving 1.7k citations

Hit Papers

Decolonizing global health: what should be the target of ... 2022 2026 2023 2024 2022 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Decolonizing global health: what should be the target of this movement and where does it lead us?
    2022 84 citations Xiaoxiao Jiang Kwete, Kun Tang et al. Global Health Research and Policy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenru Wu China 22 820 547 304 282 268 94 1.7k
Zhu Feng China 3 518 0.6× 261 0.5× 212 0.7× 222 0.8× 91 0.3× 9 1.2k
Da Xu China 24 839 1.0× 592 1.1× 609 2.0× 401 1.4× 297 1.1× 71 2.1k
Xiaodong Zhu China 25 610 0.7× 398 0.7× 692 2.3× 520 1.8× 312 1.2× 164 2.2k
Jiao Zhang China 26 1.5k 1.8× 893 1.6× 425 1.4× 425 1.5× 31 0.1× 179 2.6k
Hung‐Ming Wang Taiwan 28 537 0.7× 383 0.7× 996 3.3× 442 1.6× 85 0.3× 88 2.4k
Francesco Perri Italy 28 673 0.8× 326 0.6× 1.1k 3.5× 673 2.4× 219 0.8× 142 2.8k
Jeng‐Kai Jiang Taiwan 31 682 0.8× 568 1.0× 1.6k 5.3× 545 1.9× 171 0.6× 124 2.6k
Fabio Bassi Italy 17 304 0.4× 615 1.1× 515 1.7× 154 0.5× 190 0.7× 45 1.4k

Countries citing papers authored by Zhenru Wu

Since Specialization
Citations

This map shows the geographic impact of Zhenru Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenru Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenru Wu more than expected).

Fields of papers citing papers by Zhenru Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenru Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenru Wu. The network helps show where Zhenru Wu may publish in the future.

Co-authorship network of co-authors of Zhenru Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenru Wu. A scholar is included among the top collaborators of Zhenru Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenru Wu. Zhenru Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jie, Yongjie Zhou, Xi Xu, et al.. (2025). RBM39 promotes hepatocarcinogenesis by regulating RFX1’s alternative splicing and subsequent activation of integrin signaling pathway. Oncogene. 44(20). 1488–1503. 2 indexed citations
2.
Jiang, Lan, Zhenru Wu, Shiyu Liu, et al.. (2025). c-Kit+ cells that intercalate with crypt Lgr5+ cells are distinctively multipotent in colonic epithelium renewal and repair. Cell Death and Differentiation. 32(7). 1244–1258.
3.
Wu, Tian, Qing Xu, Lan Li, et al.. (2025). Inhibition of IRE‐1α Alleviates Pyroptosis and Metabolic Dysfunction‐Associated Steatohepatitis by Suppressing Gasdermin D. Liver International. 45(2). e16234–e16234. 4 indexed citations
4.
Liu, Zijian, et al.. (2024). UBAP2 contributes to radioresistance by enhancing homologous recombination through SLC27A5 ubiquitination in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167481–167481. 4 indexed citations
5.
Wu, Zhenru, Guoqiang Liu, Bo Zhang, et al.. (2024). Peripheral Injection of hUC‐MSCs in the Treatment of Acute Liver Failure: A Pre‐Clinical Cohort Study in Rhesus Monkeys. Stem Cells International. 2024(1). 4654912–4654912. 2 indexed citations
6.
Jiang, Hanyu, Roberto Cannella, Zhenru Wu, et al.. (2024). Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study. Radiology. 313(2). e233471–e233471. 3 indexed citations
7.
Guo, Xinyi, et al.. (2024). METTL14/miR‐29c‐3p axis drives aerobic glycolysis to promote triple‐negative breast cancer progression though TRIM9‐mediated PKM2 ubiquitination. Journal of Cellular and Molecular Medicine. 28(3). e18112–e18112. 13 indexed citations
8.
9.
10.
Ma, Wenjie, Zhenru Wu, Fei Liu, et al.. (2023). PI3K-CCL2-CCR2-MDSCs axis: A potential pathway for tumor Clostridia-promoted CD 8+ T lymphocyte infiltration in bile tract cancers. Neoplasia. 43. 100920–100920. 7 indexed citations
11.
Yuan, Jingsheng, Zijian Liu, Zhenru Wu, Jiayin Yang, & Tao Lv. (2022). Comprehensive Molecular Analysis Identified an SRSF Family-Based Score for Prognosis and Therapy Efficiency Prediction in Hepatocellular Carcinoma. Cancers. 14(19). 4727–4727. 4 indexed citations
12.
Yuan, Jingsheng, Tao Lv, Jian Yang, et al.. (2022). The lipid transporter HDLBP promotes hepatocellular carcinoma metastasis through BRAF-dependent epithelial-mesenchymal transition. Cancer Letters. 549. 215921–215921. 19 indexed citations
13.
Yuan, Jingsheng, Tao Lv, Jian Yang, et al.. (2022). HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma. Redox Biology. 58. 102546–102546. 69 indexed citations
14.
Kwete, Xiaoxiao Jiang, Kun Tang, Lucy Chen, et al.. (2022). Decolonizing global health: what should be the target of this movement and where does it lead us?. Global Health Research and Policy. 7(1). 3–3. 84 indexed citations breakdown →
15.
Zhou, Yongjie, Yuwei Chen, Xiaoyun Zhang, et al.. (2021). Brahma‐Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion. Hepatology. 74(2). 797–815. 25 indexed citations
16.
Shao, Mingyang, Qing Xu, Zhenru Wu, et al.. (2020). Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p. Stem Cell Research & Therapy. 11(1). 37–37. 155 indexed citations
17.
Zhang, Jun, Zhenru Wu, Xin Zhang, et al.. (2020). Machine learning: an approach to preoperatively predict PD-1/PD-L1 expression and outcome in intrahepatic cholangiocarcinoma using MRI biomarkers. ESMO Open. 5(6). e000910–e000910. 41 indexed citations
18.
Ma, Wenjie, Zhenru Wu, Hai‐Jie Hu, et al.. (2019). Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits. Clinics and Research in Hepatology and Gastroenterology. 44(3). 356–367. 6 indexed citations
19.
Guo, Gang, Xiang Zhuang, Qing Xu, et al.. (2019). Peripheral infusion of human umbilical cord mesenchymal stem cells rescues acute liver failure lethality in monkeys. Stem Cell Research & Therapy. 10(1). 84–84. 32 indexed citations
20.
He, Rui, Ping Yin, Li He, et al.. (2019). MiR-1a-3p mitigates isoproterenol-induced heart failure by enhancing the expression of mitochondrial ND1 and COX1. Experimental Cell Research. 378(1). 87–97. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhu Feng Breakdown of academic impact, for papers by Da Xu Breakdown of academic impact, for papers by Xiaodong Zhu Breakdown of academic impact, for papers by Jiao Zhang Breakdown of academic impact, for papers by Hung‐Ming Wang Breakdown of academic impact, for papers by Francesco Perri Breakdown of academic impact, for papers by Jeng‐Kai Jiang Breakdown of academic impact, for papers by Fabio Bassi
Rankless by CCL
2026